A total of 239 patients with ET, from February 1995 to April 2011, were retrospectively analyzed from 4 Korean academic institutions. Data were collected through the review of medical records, and vascular events were confirmed by diagnostic procedures for establishing thrombosis and hemorrhagic complications.
Of the patients (median age, 61 years; median follow-up, 51.8 months), 32 (13.4 % ) experienced thrombohemorrhagic complications. The 10-year cumulative incidence rate showed a 20.6 % incidence of thrombohemorrhagic events. In univariate analysis, the presence of JAK2 mutations, high-risk group, previous thrombohemorrhagic events, and >60 years old were shown to have higher incidences of vascular events than any other factors. In multivariate analysis, previous thrombotic events and JAK2 mutations were independent risk factors for vascular events (hazard ratio, 2.907 [95 % CI, 1.142-7.406], P =.025; and 4.146 [95 % CI 1.227-14.018], P = 0.022).
Previous thrombotic history and the JAK2 V617F mutation were associated with a higher 10-year cumulative incidence rate of thrombohemorrhagic events.